Arthur Hu to Join BD as Chief Information and Digital Officer
PRNewswire (Mon, 21-Sep 4:30 PM ET)
Stock futures rise after Wall Street rally; Fed speakers in focus
Seeking Alpha News (Fri, 18-Sep 4:09 AM ET)
BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview
PRNewswire (Mon, 14-Sep 6:50 AM ET)
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
PRNewswire (Thu, 27-Aug 6:50 AM ET)
BD to Present at Wells Fargo 21st Annual Healthcare Conference
PRNewswire (Wed, 26-Aug 4:15 PM ET)
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
PRNewswire (Mon, 17-Aug 4:30 PM ET)
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
PRNewswire (Wed, 12-Aug 6:50 AM ET)
BD Reports Third Quarter Fiscal 2026 Financial Results
PRNewswire (Thu, 6-Aug 6:30 AM ET)
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
PRNewswire (Wed, 29-Jul 6:56 AM ET)
PRNewswire (Tue, 28-Jul 4:15 PM ET)
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.
As of September 21, 2026, BDX stock price declined to $180.70 with 1,295,913 million shares trading.
BDX has a beta of 0.22, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.01 to the broad based SPY ETF.
BDX has a market cap of $51.40 billion. This is considered a Large Cap stock.
Last quarter Becton Dickinson And Company reported $5 billion in Revenue and $3.23 earnings per share. This beat revenue expectation by $96 million and exceeded earnings estimates by $.10.
In the last 3 years, BDX traded as high as $269.52 and as low as $140.11.
The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
BDX has outperformed the market in the last year with a return of +21.7%, while the SPY ETF gained +18.5%. In the last 3 month period, BDX beat the market returning +26.2%, while SPY returned +3.8%. However, in the most recent 2 weeks BDX has underperformed the stock market by returning -1.6%, while SPY returned +0.7%.
BDX support price is $178.14 and resistance is $183.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX shares will trade within this expected range on the day.
